Start-Up Nation Finder

45 companies were selected

Add smartlist note (optional)

Smartlist name*

Smartlist must have a valid name.

Description (optional)

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

The invitation to claim the profile was originally sent to

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Name*

Work Email* (please provide your email in the organization)

Position*

Notes

I agree to receive Informational Emails from Start-Up Nation Finder as defined in the Privacy Policy and Terms of Use

Already have an account?

Search Was Saved

Home > Companies > IOPtima

Claimed by owner • Last Update 10.5.2021 • Suggest Edits • Claim Profile

Claimed by owner

IOPtima

Surgical Ophthalmic Laser Devices and Accessories

Acquired by Chengdu Kanghong Pharmaceutical Group on Sep, 2018

IOPtima

www.calcalistech.com • Sep 27, 2018

Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company

en.globes.co.il • Nov 21, 2017

Chengdu Kanghong Pharma buys Israel's IOPtima for $56m

www.healio.com • Oct 2, 2017

IOPtima launches Lipitear phospholipid microemulsion

www.healio.com • Jul 12, 2017

IOPtima launches iLid CO2 laser kit for blepharoplasty

www.globes.co.il • Apr 19, 2017

BioLight to sell IOPtima to Chinese co

www.prnewswire.com • Dec 21, 2015

Bio Light's IOPtiMate[TM] System Receives Regulatory Approval in Canada

www.asianscientist.com • Mar 11, 2014

BioLight Eyes Chinese Glaucoma Market, Raises US$5.5 Million - Asian Scientist Magazine

www.bioopticsworld.com • Nov 16, 2009

https://www.bioopticsworld.com/articles/2009/11/ioptima-receives-europea-patent-approval-for-laser-system-for-treatment-of-glaucoma.html

www.israel21c.org • Sep 21, 2007

Israel's IOPtima shines a light at the end of the glaucoma tunnel

IOPtima is a rapidly growing company focused on developing minimally invasive and innovative surgical ophthalmic devices. Its flagship product, the IOPtimate, is a surgical system for the treatment of glaucoma that utilizes CO2 laser technology to significantly reduce internal eye pressure without penetrating the eye. The company also offers a line of patented eye drops to treat ocular surface diseases.

IOPtima is a Kanghong Pharmaceutical company.